Potent
Akkermansia
/ drug effects
Antioxidants
Candida
/ drug effects
Citrus
/ chemistry
Dose-Response Relationship, Drug
Drug Resistance, Microbial
Faecalibacterium prausnitzii
/ drug effects
Gastrointestinal Microbiome
/ drug effects
Humans
Irritable Bowel Syndrome
/ microbiology
Lactobacillus
/ drug effects
Oils, Volatile
/ isolation & purification
Plant Extracts
/ isolation & purification
Probiotics
Saccharomyces cerevisiae
/ drug effects
Vitis
/ chemistry
Akkermansia muciniphila
Candida species
Citrus aurantium var. amara essential oil
Saccharomyces cerevisiae
Vitis vinifera cv Italia hydrolate
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
07 May 2020
07 May 2020
Historique:
received:
06
03
2020
revised:
25
04
2020
accepted:
27
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
17
2
2021
Statut:
epublish
Résumé
Irritable bowel syndrome (IBS) is a functional disorder without any pathological alteration, in which the alterations of the The effectiveness of 6 essential oils and 2 hydrolates was evaluated using microbiological tests, carried out on 50 clinical isolates ( The study led to a mixture based on a 1/100 ratio of
Sections du résumé
BACKGROUND
BACKGROUND
Irritable bowel syndrome (IBS) is a functional disorder without any pathological alteration, in which the alterations of the
METHODS
METHODS
The effectiveness of 6 essential oils and 2 hydrolates was evaluated using microbiological tests, carried out on 50 clinical isolates (
RESULTS
RESULTS
The study led to a mixture based on a 1/100 ratio of
Identifiants
pubmed: 32392768
pii: nu12051329
doi: 10.3390/nu12051329
pmc: PMC7284808
pii:
doi:
Substances chimiques
Antioxidants
0
Oils, Volatile
0
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Expert Opin Investig Drugs. 2001 Jul;10(7):1211-22
pubmed: 11772245
Digestion. 2019;100(2):127-138
pubmed: 30423561
Nat Rev Microbiol. 2017 Feb;15(2):96-108
pubmed: 27867199
United European Gastroenterol J. 2016 Jun;4(3):353-62
pubmed: 27403301
J Gastrointestin Liver Dis. 2016 Jun;25(2):151-7
pubmed: 27308645
World J Gastroenterol. 2017 Jan 14;23(2):336-344
pubmed: 28127207
Middle East J Dig Dis. 2013 Oct;5(4):217-22
pubmed: 24829694
J Clin Gastroenterol. 2011 Sep;45(8):679-83
pubmed: 21301358
J Ethnopharmacol. 2016 Dec 24;194:937-946
pubmed: 27815079
BMC Complement Altern Med. 2013 Nov 28;13:338
pubmed: 24283351
Am J Gastroenterol. 2016 Aug;111(8):1165-76
pubmed: 27272011
Phytother Res. 2015 Oct;29(10):1628-33
pubmed: 26235937
Biochim Biophys Acta. 2015 Nov;1848(11 Pt A):2868-77
pubmed: 26325345
J Nutr Intermed Metab. 2018 Mar;11:1-8
pubmed: 29568797
Nat Rev Gastroenterol Hepatol. 2010 Mar;7(3):163-73
pubmed: 20101257
Intest Res. 2016 Oct;14(4):297-304
pubmed: 27799880
J Toxicol Environ Health B Crit Rev. 2013;16(1):17-38
pubmed: 23573938
Gut. 2017 Jun;66(6):1039-1048
pubmed: 26843508
Ann Gastroenterol. 2018 Nov-Dec;31(6):685-691
pubmed: 30386118
Eur J Gastroenterol Hepatol. 2005 Jan;17(1):21-6
pubmed: 15647635
J Nutr Biochem. 2011 Apr;22(4):380-7
pubmed: 20655715
Ann Allergy. 1985 Jun;54(6):538-40
pubmed: 4014782
Int J Mol Sci. 2018 Jul 05;19(7):
pubmed: 29976894
Mymensingh Med J. 2013 Jan;22(1):27-30
pubmed: 23416804
J Diet Suppl. 2019;16(1):119-128
pubmed: 29333891
Neurogastroenterol Motil. 2014 Jul;26(7):1036-48
pubmed: 24796536
Gastroenterology. 2017 Oct;153(4):1026-1039
pubmed: 28624575
Neurogastroenterol Motil. 2017 May;29(5):
pubmed: 27981684
Front Cell Infect Microbiol. 2018 Sep 07;8:281
pubmed: 30245977
J Food Sci. 2014 Mar;79(3):M369-77
pubmed: 24506214
Clin Epidemiol. 2014 Feb 04;6:71-80
pubmed: 24523597
Gastroenterol Res Pract. 2012;2012:457150
pubmed: 22811700
Front Microbiol. 2016 Aug 03;7:1227
pubmed: 27536299
Cochrane Database Syst Rev. 2013 Nov 13;(11):CD009710
pubmed: 24222383